New diagnostic tools are trying to shrink endometriosis's decade long diagnosis gap
Dr. Dereck Mush, MD, MBA
DotLab
Healthcare technology company developing blood-based diagnostic tests for endometriosis detection.
What they do
The company focuses on expanding clinical diagnostics for women's health by developing the first non-invasive blood test for endometriosis. Utilizing biomarker-based detection technology, the product aims to reduce the time to diagnosis for patients suffering from chronic pelvic pain, which typically requires surgical verification.
The record
- Vertical
- Women's Health
- Sub-segment
- Endometriosis testing
- Product type
- Diagnostics
- Stage
- Series A
- Headquarters
- San Francisco, USA
- Region
- North America
- Founded
- 2016
- Total funding
- $16M raised
Notable investors: Tiger Global Management, Kapor Capital, Y Combinator.
Also in Women's Health
Related on The Signal
Dr. Dereck Mush, MD, MBA
The Curative Adjuvant Checkpoint Pivot: How Genentech's ATOMIC Approval Redefines Early GI Oncology Economics and Reflex Testing Infrastructure
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
At-home semen analysis is turning a taboo test into a routine one
At-home semen analysis is turning a taboo test into a routine one
Dr. Dereck Mush, MD, MBA
Self collection cervical screening kits are moving from pilot to mainstream option
Dr. Dereck Mush, MD, MBA